Last updated on June 2019

Safety and Efficacy of VAY736 in Patients With Primary Sjogren's Syndrome (pSS)


Brief description of study

This study will determine the dose-response relationship of VAY736 for key efficacy and safety parameters

Clinical Study Identifier: NCT02962895

Find a site near you

Start Over

Novartis Investigative Site

Boca Raton, FL United States
  Connect »

Novartis Investigative Site

Jacksonville, FL United States
  Connect »

Novartis Investigative Site

Plantation, FL United States
  Connect »

Novartis Investigative Site

Indianapolis, IN United States
  Connect »

Novartis Investigative Site

Baltimore, MD United States
  Connect »

Novartis Investigative Site

New York, NY United States
  Connect »

Novartis Investigative Site

Rochester, NY United States
  Connect »

Novartis Investigative Site

Pittsburgh, PA United States
  Connect »

Novartis Investigative Site

Wexford, PA United States
  Connect »

Novartis Investigative Site

Charleston, SC United States
  Connect »

Novartis Investigative Site

Houston, TX United States
  Connect »

Novartis Investigative Site

San Antonio, TX United States
  Connect »

Novartis Investigative Site

Ciudad Autonoma de Bs As, Argentina
  Connect »

Novartis Investigative Site

Le Kremlin Bicetre, France
  Connect »

Novartis Investigative Site

Ekaterinburg, Russian Federation
  Connect »

Novartis Investigative Site

Orenburg, Russian Federation
  Connect »

Novartis Investigative Site

St Petersburg, Russian Federation
  Connect »

Novartis Investigative Site

Westcliff-on-Sea, United Kingdom
  Connect »

Novartis Investigative Site

Birmingham, United Kingdom
  Connect »

Novartis Investigative Site

Liverpool, United Kingdom
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.